TGFBI and breast carcinoma: In TGFBI highly expressed breast cancer patients, the percentage of PR + was 17.3 ± 3.2, while, in TGFBI lowly expressed breast cancer patients, the percentage of PR + was 31.8 ± 6 (Fig. 4c).